The mouse RANKL gene locus is defined by a broad pattern of histone H4 acetylation and regulated through distinct distal enhancers

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 2030-2045

  Martowicz, Melissa L ^a   Meyer, Mark B ^a   Pike, J Wesley ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chip analysis; Chromatin; Histone acetylation; RANKL; RNA pol II; Transactivation; VDR

Indexed keywords

CALCITRIOL; GENOMIC DNA; HISTONE H4; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN RAD21; RNA POLYMERASE II; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR IIB; TRANSCRIPTION FACTOR IID; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE LOCUS; HISTONE ACETYLATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ANALYSIS; RNA TRANSCRIPTION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

ACETYLATION; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; GENETIC LOCI; HISTONES; INSULATOR ELEMENTS; MICE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; RANK LIGAND; RECEPTORS, CALCITRIOL; REPRESSOR PROTEINS; RESPONSE ELEMENTS; RNA POLYMERASE II; TRANSCRIPTION FACTOR TFIIB; TRANSCRIPTION, GENETIC;

EID: 79960344540     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23123     Document Type: Article

References (62)

1. Birney E, Stamatoyannopoulos J, Dutta A, Guigõ R, Gingeras T, Margulies E, Weng Z, Snyder M, Dermitzakis E, Thurman R, Kuehn M, Taylor C, Neph S, Koch C, Asthana S, Malhotra A, Adzhubei I, Greenbaum J, Andrews R, Flicek P, Boyle P, Cao H, Carter N, Clelland G, Davis S, Day N, Dhami P, Dillon S, Dorschner M, Fiegler H, Giresi P, Goldy J, Hawrylycz M, Haydock A, Humbert R, James K, Johnson B, Johnson E, Frum T, Rosenzweig E, Karnani N, Lee K, Lefebvre G, Navas P, Neri F, Parker S, Sabo P, Sandstrom R, Shafer A, Vetrie D, Weaver M, Wilcox S, Yu M, Collins F, Dekker J, Lieb J, Tullius T, Crawford G, Sunyaev S, Noble W, Dunham I, Denoeud F, Reymond A, Kapranov P, Rozowsky J, Zheng D, Castelo R, Frankish A, Harrow J, Ghosh S, Sandelin A, Hofacker I, Baertsch R, Keefe D, Dike S, Cheng J, Hirsch H, Sekinger E, Lagarde J, Abril J, Shahab A, Flamm C, Fried C, Hackermüller J, Hertel J, Lindemeyer M, Missal K, Tanzer A, Washietl S, Korbel J, Emanuelsson O, Pedersen J, Holroyd N, Taylor R, Swarbreck D, Matthews N, Dickson M, Thomas D, Weirauch M, Gilbert J,., et al. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816. (Pubitemid 46920138)
2. Brownell J, Allis C,. 1996. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6: 176-184. (Pubitemid 26120391)
3. 3 24-hydroxylase. Mol Cell Biol 25: 472-487. (Pubitemid 40039836)
4. II250 is a bipartite protein kinase that phosphorylates the base transcription factor RAP74. Cell 84: 781-790.
5. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G,. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520. (Pubitemid 40477060)
6. Ewing A, Attner M, Chakravarti D,. 2007. Novel regulatory role for human Acf1 in transcriptional repression of vitamin D3 receptor-regulated genes. Mol Endocrinol 21: 1791-1806. (Pubitemid 47173792)
7. Fan X, Roy EM, Murphy TC, Nanes MS, Kim S, Pike JW, Rubin J,. 2004. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells. J Cell Biochem 93: 807-818. (Pubitemid 44264175)
8. Feng W, Liu Y, Wu J, Nephew KP, Huang TH, Li L,. 2008. A Poisson mixture model to identify changes in RNA polymerase II binding quantity using high-throughput sequencing technology. BMC Genomics 9 (Suppl 2): S23.
9. Filippova G,. 2008. Genetics and epigenetics of the multifunctional protein CTCF. Curr Top Dev Biol 80: 337-360.
10. Fu Q, Manolagas SC, O'Brien CA,. 2006. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol 26: 6453-6468. (Pubitemid 44277886)
11. Galli C, Zella LA, Fretz JA, Fu Q, Pike JW, Weinstein RS, Manolagas SC, O'Brien CA,. 2008. Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass. Endocrinology 149: 146-153.
12. Gilchrist DA, Fargo DC, Adelman K,. 2009. Using ChIP-chip and ChIP-seq to study the regulation of gene expression: genome-wide localization studies reveal widespread regulation of transcription elongation. Methods 48: 398-408.
13. Groyer A, Schweizer-Groyer G, Cadepond F, Mariller M, Baulieu EE,. 1987. Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro. Nature 328: 624-626. (Pubitemid 17103964)
14. Guttman M, Amit I, Garber M, French C, Lin M, Feldser D, Huarte M, Zuk O, Carey B, Cassady J, Cabili M, Jaenisch R, Mikkelsen T, Jacks T, Hacohen N, Bernstein B, Kellis M, Regev A, Rinn J, Lander E,. 2009. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227.
15. Harris WH, Heaney RP,. 1969. Skeletal renewal and metabolic bone disease. N Engl J Med 280: 303-311 concl.
16. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ,. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96: 3540-3545. (Pubitemid 29168945)
17. Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T,. 1999a. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163: 434-442. (Pubitemid 29295871)
18. Jimi E, Nakamura I, Duong L, Ikebe T, Takahashi N, Rodan G, Suda T,. 1999b. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247: 84-93. (Pubitemid 29393964)
19. Jones J, Phatnani H, Haystead T, MacDonald J, Alam S, Greenleaf A,. 2004. C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats. J Biol Chem 279: 24957-24964. (Pubitemid 38756743)
20. Kabe Y, Yamada J, Uga H, Yamaguchi Y, Wada T, Handa H,. 2005. NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Mol Cell Biol 25: 512-522. (Pubitemid 40039839)
21. 3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res 20: 305-317.
22. Kim S, Yamazaki M, Shevde N, Pike J,. 2007a. Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol Endocrinol 21: 197-214. (Pubitemid 46041700)
23. Kim S, Yamazaki M, Shevde NK, Pike JW,. 2007b. Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol Endocrinol 21: 197-214. (Pubitemid 46041700)
24. 3 is mediated through multiple long-range enhancers. Mol Cell Biol 26: 6469-6486. (Pubitemid 44277887)
25. 3 is mediated through multiple long-range enhancers. Mol Cell Biol 26: 6469-6486. (Pubitemid 44277887)
26. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, Wu Y, Green RD, Ren B,. 2005b. A high-resolution map of active promoters in the human genome. Nature 436: 876-880. (Pubitemid 41160649)
27. Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D, Ogawa S, Unno K, Okubo M, Tokita A, Nakagawa T, Ito T, Ishimi Y, Nagasawa H, Matsumoto T, Yanagisawa J, Kato S,. 2003. The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113: 905-917. (Pubitemid 36792033)
28. Kitazawa R, Kitazawa S,. 2002. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Biochem Biophys Res Commun 290: 650-655. (Pubitemid 34687489)
29. 3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J Cell Biochem 89: 771-777. (Pubitemid 36759137)
30. Kondo H, Guo J, Bringhurst F,. 2002. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J Bone Miner Res 17: 1667-1679.
31. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM,. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
32. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ,. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176. (Pubitemid 28180851)
33. Lin PS, Marshall NF, Dahmus ME,. 2002. CTD phosphatase: role in RNA polymerase II cycling and the regulation of transcript elongation. Prog Nucleic Acid Res Mol Biol 72: 333-365.
34. Liu BY, Guo J, Lanske B, Divieti P, Kronenberg HM, Bringhurst FR,. 1998. Conditionally immortalized murine bone marrow stromal cells mediate parathyroid hormone-dependent osteoclastogenesis in vitro. Endocrinology 139: 1952-1964. (Pubitemid 28513857)
35. Mangelsdorf DJ, Evans RM,. 1995. The RXR heterodimers and orphan receptors. Cell 83: 841-850. (Pubitemid 26006526)
36. Marshall NF, Peng J, Xie Z, Price DH,. 1996. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J Biol Chem 271: 27176-27183. (Pubitemid 26359140)
37. Mizzen C, Yang X, Kokubo T, Brownell J, Bannister A, Owen-Hughes T, Workman J, Wang L, Berger S, Kouzarides T, Nakatani Y, Allis C,. 1996. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 87: 1261-1270. (Pubitemid 27010109)
38. Mundy GR,. 2000. Pathogenesis of osteoporosis and challenges for drug delivery. Adv Drug Deliv Rev 42: 165-173. (Pubitemid 30645776)
39. 3. Mol Endocrinol 22: 1044-1056. (Pubitemid 351629606)
40. O'Brien CA, Kern B, Gubrij I, Karsenty G, Manolagas SC,. 2002. Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone 30: 453-462. (Pubitemid 34204119)
41. Oberley MJ, Farnham PJ,. 2003. Probing chromatin immunoprecipitates with CpG-island microarrays to identify genomic sites occupied by DNA-binding proteins. Methods Enzymol 371: 577-596. (Pubitemid 37542759)
42. Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, Rosenfeld MG,. 1999. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13: 3198-3208. (Pubitemid 30030442)
43. Pham A, Sauer F,. 2000. Ubiquitin-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila. Science 289: 2357-2360.
44. Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, Simon I, Zeitlinger J, Schreiber J, Hannett N, Kanin E, Volkert TL, Wilson CJ, Bell SP, Young RA,. 2000. Genome-wide location and function of DNA binding proteins. Science 290: 2306-2309. (Pubitemid 32041573)
45. Rinn J, Kertesz M, Wang J, Squazzo S, Xu X, Brugmann S, Goodnough L, Helms J, Farnham P, Segal E, Chang H,. 2007. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323. (Pubitemid 46962090)
46. Roccisana J, Kawanabe N, Kajiya H, Koide M, Roodman G, Reddy S,. 2004. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells. J Biol Chem 279: 10500-10507. (Pubitemid 38372660)
47. Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton D, Suda T, Ng K, Martin T,. 1996. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 183: 2581-2591. (Pubitemid 26192368)
48. Srivastava S, Matsuda M, Hou Z, Bailey JP, Kitazawa R, Herbst MP, Horseman ND,. 2003. Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells. J Biol Chem 278: 46171-46178. (Pubitemid 37432768)
49. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ,. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357. (Pubitemid 30649812)
50. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 123: 1504-1510.
51. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 123: 1504-1510.
52. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T,. 1993. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90: 11924-11928. (Pubitemid 24008752)
53. Teitelbaum SL,. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
54. Tominaga H, Maeda S, Hayashi M, Takeda S, Akira S, Komiya S, Nakamura T, Akiyama H, Imamura T,. 2008. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Mol Biol Cell 19: 5373-5386.
55. Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, Chojkier M,. 1993. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364: 544-547. (Pubitemid 23273102)
56. Verrijzer C, Chen J, Yokomori K, Tjian R,. 1995. Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell 81: 1115-1125.
57. Wani M, Fuller K, Kim N, Choi Y, Chambers T,. 1999. Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology 140: 1927-1935. (Pubitemid 29149267)
58. Wassarman D, Sauer F,. 2001. TAF(II)250: a transcription toolbox. J Cell Sci 114: 2895-2902.
59. Wendt KS, Peters JM,. 2009. How cohesin and CTCF cooperate in regulating gene expression. Chromosome Res 17: 201-214.
60. Wendt KS, Yoshida K, Itoh T, Bando M, Koch B, Schirghuber E, Tsutsumi S, Nagae G, Ishihara K, Mishiro T, Yahata K, Imamoto F, Aburatani H, Nakao M, Imamoto N, Maeshima K, Shirahige K, Peters JM,. 2008. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 451: 796-801. (Pubitemid 351253176)
61. 3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J Biol Chem 278: 31756-31765. (Pubitemid 37048356)
62. 3 actions on ion channels in osteoblasts. Steroids 71: 291-297.